Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 2000
Primary Completion Date
March 31, 2003
Conditions
Cancer
Interventions
DRUG
caspofungin acetate
DRUG
liposomal amphotericin B
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00008359 - Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment | Biotech Hunter | Biotech Hunter